Endotronix Raises $45M in Series D Financing
Summary
Endotronix, Inc. , a Lisle, Ill.-based digital health, medtech company dedicated to advancing the treatment of heart failure, closed a $45m Series D financing round.Endotronix will also expand the board of directors to include Fouad Azzam Ph.D., General Partner at LSP.The product platform consists of a comprehensive remote patient management software solution coupled with an integrated, next generation implantable pulmonary artery sensor to streamline heart failure care management and provide early detection of worsening heart failure.Led by Harry Rowland, CEO, Endotronix is advancing the Cordella System, a proactive heart failure management solution that allows physicians to treat more patients with guideline-based therapy.The system extends clinical care into the home by collecting and transmitting daily patient data and insights to the heart failure clinician to guide therapy and optimal dosing.